Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue

Blood

Volumn 91, Issue 4, 1998, Pages 1373-1381

  Tao, Qian ^b   Robertson, Keith D ^b   Manns, Angela ^b   Hildesheim, Allan ^b   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BURKITT LYMPHOMA; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SERODIAGNOSIS; STRAIN DIFFERENCE; TISSUE CULTURE;

EID: 0032520028     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.4.1373     Document Type: Article

References (76)

1. Magrath I: The Pathogenesis of Burkitt's Lymphoma, in Advances in Cancer Research. San Diego, CA, Academic, 1990, p 133
2. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, Dalla-Favera R: Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 77:1092, 1991
3. Niedobitek G, Agathanggelou A, Rowe M, Jones EL, Jones DB, Turyaguma P, Oryema J, Wright DH, Young LS: Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 86:659, 1995
4. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla-Favera R, Neri A, Guttierez M, Levine P, Magrath I: Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: Relevance to geography and Epstein-Barr virus association. Blood 77:1516, 1991
5. Anwar N, Kingma DW, Bloch AR, Mourad M, Raffeld M, Franklin J, Magrath I, Bolkainy NE, Jaffe ES: The investigation of Epstein-Barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt: Epidemiological correlations. Cancer 76:1245, 1995
6. Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H: Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil. Blood 87:5279, 1996
7. Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R: Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667, 1988
8. Hamilton-Dutoit SJ, Rea D, Raphael M, Sandvej K, Delecluse J, Gisselbrecht C, Marelle L, van Krieken JHJM, Pallesen G: Epstein-Barr virus latent gene expression and tumor cell phenotype in AIDS-related non-Hodgkin's lymphoma. Am J Pathol 143:1072, 1993
9. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinh JP, Pedersen C: AIDS-related lymphoma: Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 138:149, 1991
10. Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB: Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66:122, 1992
11. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, Rickinson AB: Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 187:189, 1992
12. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H, Rickinson AB: Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6:2743, 1987
13. Altiok E, Minarovits J, Hu LF, Contreras-Brodin B, Klein G, Ernberg I: Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6. Proc Natl Acad Sci USA 89:905, 1992
14. Schlager S, Speck SH, Woisetschlaeger M: Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA 1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection of B cells. J Virol 70:3561, 1996
15. Brooks L, Yao QY, Rickinson AB, Young LS: Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1 and LMP2 transcripts. J Virol 66:2689, 1992
16. Deacon EM, Pallesen G, Niedobitek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339, 1993
17. Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, Raab-Traub N: Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66:3257, 1992
18. Chen CL, Sadler RH, Walling DM, Su IJ, Hsieh HC, Raab-Traub N: Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. J Virol 67:6303, 1993
19. Minarovits J, Hu L-F, Imai S, Harabuchi Y, Kataura A, Minarovits-Kormuta S, Osato T, Klein G: Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas. J Gen Virol 75:77, 1994
20. Chiang AKS, Tao Q, Srivastava G, Ho FCS: Nasal NK-and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease. Int J Cancer 68:285, 1996
21. van Gorp J, Brink A, Oudejans JJ, van den Brule AJC, van den Tweel JG, Jiwa NM, De Bruin PC, Meijer CJLM: Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas. J Clin Pathol 49:72, 1996
22. Carbone A, Gloghini A, Zagonel V, Tirelli U: Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas. Blood 87:1202, 1996
23. Rickinson AB, Young LS, Rowe M: Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol 61:1310, 1987
24. Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF: CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease. Blood 88: 3129,1996
25. Robertson KD, Hayward DJ, Ling PD, Samid D, Ambinder RF: Transcriptional activation of the EBV latency C promoter following 5-azacytidine treatment: Evidence that demethylation at a single CpG site is crucial. Mol Cell Biol 15:6150, 1995
26. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89:1827, 1992
27. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A: Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084, 1990
28. Chen M-L, Tsai C-N, Liang C-L, Shu C-H, Huang C-R, Sulitzeanu D, Liu S-T, Chang Y-S: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131, 1992
29. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937, 1993
30. Schaefer BC, Strominger JL, Speck SH: Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group 1 Burkitt lymphoma cell lines. Proc Natl Acad Sci USA 92:10565, 1995
31. Tsai CN, Liu ST, Chang YS: Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. DNA Cell Biol 14:767, 1995
32. Nonkwelo C, Skinner J, Bell A, Rickinson A, Sample J: Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J Virol 70:623, 1996
33. Qu L, Rowe DT: Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 66:3715, 1992
34. Tierney RJ, Steven N, Young LS, Rickinson AB: Epstein-Barr virus latency in blood mononuclear cells - analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374, 1994
35. Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, Ernberg I: A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J Virol 69:3752, 1995
36. Miyashita EM, Yang B, Lam KM, Crawford DH, Thorley-Lawson DA: A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593, 1995
37. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA: Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71:4882, 1997
38. Longnecker R, Miller CL, Miao XQ, Marchini A, Kieff E: The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J Virol 66:6461, 1992
39. Brielmeier M, Mautner J, Laux G, Hammerschmidt W: The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization. J Gen Virol 77:2807, 1996
40. Miller CL, Lee JH, Kieff E, Longnecker R: An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci USA 91:772, 1994
41. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE: EBV gene expression in an NPC-related tumour. EMBO J 8:2639, 1989
42. Chen HL, Lung MML, Sham JST, Choy DTK, Griffin BE, Ng MH: Transcription of BamHI A region of the EBV genome in NPC tissues and B cells. Virology 191:193, 1992
43. Zhang CX, Lowrey P, Finerty S, Morgan AJ: Analysis of EBV gene transcription in lymphoma induced by the virus in the cottontop tamarin by construction of a cDNA library with RNA extracted from a tumor biopsy. J Gen Virol 74:509, 1993
44. Smith PR, Gao Y, Karran L, Jones MD, Snudden D, Griffin BE: Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 67:3217, 1993
45. Sadler RH, Raab-Traub N: Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 69:1132, 1995
46. Fries KL, Sculley TB, Webster-Cyriaque J, Rajadurai P, Sadler RH, Raab-Traub N: Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol 71:2765, 1997
47. Tao Q, Ho FC, Loke SL, Srivastava G: Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Int J Cancer 60:315, 1995
48. Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH: Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci USA 88:6550, 1991
49. Schaefer BC, Strominger JL, Speck SH: The Epstein-Barr virus BAMHI F promoter is an early lytic promoter: Lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol 69:5039, 1995
50. Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB: The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into lytic cycle. J Virol 66:7461, 1992
51. Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G: The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Gen Virol 70:2989, 1989
52. Minarovits J, Hu LF, Marcsek Z, Minarovits-Kormuta S, Klein G, Ernberg I: RNA polymerase III-transcribed EBER 1 and 2 transcription units are expressed and hypomethylated in the major Epstein-Barr virus-carrying cell types. J Gen Virol 73:1687, 1992
53. Jansson A, Masucci M, Rymo L: Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines. J Virol 66:62, 1992
54. Minarovits J, Li-Fu H, Minarovits-Kormuta S, Klein G, Ernberg, I: Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions. Virology 200:661, 1994
55. Nonkwelo CB, Long WK: Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation. Virology 197:205, 1993
56. Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B, Falk K, Klein G, Ernberg I: Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. J Gen Virol 72:1591, 1991
57. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T: Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131, 1994
58. Schaefer BC, Strominger JL, Speck SH: Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17:364, 1997
59. Bird AP: Functions for DNA methylation in vertebrates. Cold Spring Harb Symp Quant Biol 58:281, 1993
60. Khanim F, Yao QY, Niedobitek G, Sihota S, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491, 1996
61. Lin JC, Lin SC, De BK, Chan WP, Evatt BL: Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 81:3372, 1993
62. Frank D, Cesarman E, Liu YF, Michler RE, Knowles DM: Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 85:1396, 1995
63. Goldschmidts WL, Bhatia K, Johnson JF, Akar N, Gutierrez MI, Shibata D, Carolan M, Levine A, Magrath IT: Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 6:875, 1992
64. Zimber U, Aldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U, Freese U, Bornkamm GW: Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56, 1986
65. Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB: New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68:2853, 1987
66. Boyle MJ, Sculley TB, Penny R, Sewell WA, Tschuchnigg M, Berger MF, Cooper DA: The role of EBV subtypes in HIV-associated lymphoma. Leuk Lymphoma 10:17, 1993
67. Sixbey JW, Chesney PJ, Resnick L, Shirley P, Buntin DM: Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761, 1989
68. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E: The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389, 1995
69. Knecht H, Raphael M, McQuain C, Rothenberger S, Pihan G, Camilleribroet S, Bachmann E, Kershaw GR, Ryan S, Kittler ELW, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P: Deletion variants within the NF-kappa-B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 87:876, 1996
70. Knecht H, Bachmann E, Brousset P, Rothenberger S, Einsele H, Lestou VS, Delsol G, Bachmann F, Ambros PF, Odermatt BF: Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523, 1995
71. Li SN, Chang YS, Liu ST: Effect of a 10-amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129, 1996
72. Baichwal VR, Sugden B: Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene 2:461, 1988
73. Wang D, Liebowitz D, Kieff E: An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831, 1985
74. Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G: Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. Eur J Immunol 30A:84, 1994
75. Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M, Young LS: Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899, 1997
76. Rothenberger S, Bachmann E, Berger C, McQuain C, Odermatt BF, Knecht H: Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription. Oncogene 14:2123, 1997